Related Experiment Video
Updated: Jul 17, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues
A L Aguiar1, A C Couto-Silva, E J Vicente
1Department of Pediatrics, Federal University of Bahia School of Medicine, Brazil.
Unlabelled:
Data concerning the effects of GnRHa on weight gain are scarce.
Objective:
To assess the variation of the body mass index (BMI) in girls during GnRHa treatment for idiopathic central precocious puberty (CPP).
Patients And Methods:
Semestral anthropometric data from 176 girls treated with goserelin or leuprorelin were analyzed.
Results:
BMI z-score increased from 1.5 +/- 0.1 SD before treatment (n = 176) to 1.7 +/- 0.2 SD after 24 months (n = 61, p = 0.008). In girls with normal weight before treatment, this variation was greater (n = 112, 0.2 +/- 0.1 SD, p = 0.01) than in those who were overweight (n = 63, -0.9 +/- 0.2 SD, p = 0.7). In the goserelin group the weight change adjusted for bone age was greater (n = 28, 0.4 +/- 0.1 SD) than in the leuprorelin group (n = 5, 0.04 +/- 0.1 SD, p = 0.05).
Conclusions:
A slight increase in BMI was noted, mainly in girls with normal weight before treatment. The influence of different GnRHa on weight must be further investigated.
Related Concept Videos
Signs of Puberty
Hormonal Regulation
Hormonal Regulation
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Drug Dosing: Obese Patients
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
